Cargando…
Antimicrobial Peptides
The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill “superbugs” emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial pep...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873676/ https://www.ncbi.nlm.nih.gov/pubmed/24287494 http://dx.doi.org/10.3390/ph6121543 |
_version_ | 1782297136778444800 |
---|---|
author | Bahar, Ali Adem Ren, Dacheng |
author_facet | Bahar, Ali Adem Ren, Dacheng |
author_sort | Bahar, Ali Adem |
collection | PubMed |
description | The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill “superbugs” emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial peptides (AMPs), a growing class of natural and synthetic peptides with a wide spectrum of targets including viruses, bacteria, fungi, and parasites. We summarize the major types of AMPs, their modes of action, and the common mechanisms of AMP resistance. In addition, we discuss the principles for designing effective AMPs and the potential of using AMPs to control biofilms (multicellular structures of bacteria embedded in extracellular matrixes) and persister cells (dormant phenotypic variants of bacterial cells that are highly tolerant to antibiotics). |
format | Online Article Text |
id | pubmed-3873676 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-38736762014-01-06 Antimicrobial Peptides Bahar, Ali Adem Ren, Dacheng Pharmaceuticals (Basel) Review The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill “superbugs” emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial peptides (AMPs), a growing class of natural and synthetic peptides with a wide spectrum of targets including viruses, bacteria, fungi, and parasites. We summarize the major types of AMPs, their modes of action, and the common mechanisms of AMP resistance. In addition, we discuss the principles for designing effective AMPs and the potential of using AMPs to control biofilms (multicellular structures of bacteria embedded in extracellular matrixes) and persister cells (dormant phenotypic variants of bacterial cells that are highly tolerant to antibiotics). MDPI 2013-11-28 /pmc/articles/PMC3873676/ /pubmed/24287494 http://dx.doi.org/10.3390/ph6121543 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Bahar, Ali Adem Ren, Dacheng Antimicrobial Peptides |
title | Antimicrobial Peptides |
title_full | Antimicrobial Peptides |
title_fullStr | Antimicrobial Peptides |
title_full_unstemmed | Antimicrobial Peptides |
title_short | Antimicrobial Peptides |
title_sort | antimicrobial peptides |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873676/ https://www.ncbi.nlm.nih.gov/pubmed/24287494 http://dx.doi.org/10.3390/ph6121543 |
work_keys_str_mv | AT baharaliadem antimicrobialpeptides AT rendacheng antimicrobialpeptides |